Litcius/Paper detail

TP53 or CDKN2A/B covariation in ALK/RET/ROS1-rearranged NSCLC is associated with a high TMB, tumor immunosuppressive microenvironment and poor prognosis

Bin Jiang, Liwen Hu, Daling Dong, Zixin Guo, Wei Wei, Chao Wang, Weikang Shao, Ting Ma, Yanhui Chen, Qingyun Li, Weidong Hu

2023Journal of Cancer Research and Clinical Oncology18 citationsDOIOpen Access PDF

Topics & Concepts

CDKN2AROS1Cancer researchTumor microenvironmentLung cancerOncologyInternal medicineBiologyMedicineCancerAdenocarcinomaLung Cancer Treatments and MutationsCancer-related Molecular PathwaysLung Cancer Research Studies
TP53 or CDKN2A/B covariation in ALK/RET/ROS1-rearranged NSCLC is associated with a high TMB, tumor immunosuppressive microenvironment and poor prognosis | Litcius